Martin Edwards
Director, CoLucid Pharmaceuticals, Inc.
Companies
- Verona PharmaBoard member Feb 3, 2021 to now1
- Inozyme Pharma, Inc.Board member Jul 23, 2020 to now2
- Morphic Holding, Inc.Board member Dec 3, 2020 to Aug 21, 20243
- REATA PHARMACEUTICALS INCBoard member Aug 4, 2020 to Sep 26, 20234
- KalVista Pharmaceuticals, Inc.Board member Jun 28, 2019 to Oct 4, 20215
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- REATA PHARMACEUTICALS INC0 shares6Sep 26, 2023
Verona Pharma VRP0 shares7Oct 7, 2025- Morphic Holding, Inc.0 shares8Aug 16, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 7, 2025Returned to company 72,000 shares of Verona Pharma7
- Oct 7, 2025Exercised options 72,000 shares of Verona Pharma7
- Oct 7, 2025Returned to company 157,992 shares of Verona Pharma7
- Aug 1, 2025Sold 10,808 shares at $13.14 of Verona Pharma9
- Aug 1, 2025Exercised options 24,000 shares of Verona Pharma9
- Aug 16, 2024Returned to company 2,376 shares of Morphic Holding, Inc.8
- Nov 20, 2023Bought 33,736 shares at $1.84 of Verona Pharma10
- Nov 13, 2023Bought 2,376 shares at $20.54 of Morphic Holding, Inc.11
- Sep 26, 2023Returned to company 6,116 shares of REATA PHARMACEUTICALS INC6
- Jun 7, 2023Granted 1,682 shares at $93.61 of REATA PHARMACEUTICALS INC12
- Jun 7, 2023Granted 133 shares at $93.61 of REATA PHARMACEUTICALS INC12
- Jun 8, 2022Granted 3,883 shares at $34.76 of REATA PHARMACEUTICALS INC13
- Jun 8, 2022Granted 359 shares at $34.76 of REATA PHARMACEUTICALS INC13
- Jan 3, 2022Granted 59 shares at $27.32 of REATA PHARMACEUTICALS INC14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVerona Pharma, Board member
- 2SEC EDGARInozyme Pharma, Inc., Board member
- 3SEC EDGARMorphic Holding, Inc., Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Aug 5, 2025
- 10SEC EDGARForm 4 filed Nov 22, 2023
- 11SEC EDGARForm 4 filed Nov 15, 2023
- 12SEC EDGARForm 4 filed Jun 9, 2023
- 13SEC EDGARForm 4 filed Jun 9, 2022
- 14SEC EDGARForm 4 filed Jan 5, 2022